-transparent.png){kind=logo}
L-Threo-DOPS, a noradrenaline (NA) precursor, produced a dose-dependent increase in the volume of urine in mice and rats. It also increased the total output of sodium and chloride ions, but not the excretion of potassium ion. Treatment with peripheral decarboxylase inhibitors antagonized not only the diuretic action, but also the increase in the concentration of kidney NA produced by L-threo-DOPS. These results suggest that the diuretic action of L-threo-DOPS might not be due to its direct action, but largely to NA formed by its decarboxylation in the kidney.
Related Publications
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
March 1990,
Japanese journal of pharmacology,
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
December 1981,
The Journal of pharmacy and pharmacology,
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
August 1996,
Clinical autonomic research : official journal of the Clinical Autonomic Research Society,
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
January 1997,
Journal of the autonomic nervous system,
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
July 1978,
The Journal of pharmacy and pharmacology,
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
December 1992,
Experientia,
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
February 1994,
British journal of pharmacology,
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
January 1987,
Japanese journal of pharmacology,
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
November 1972,
Experientia,
J Katsube, and
T Kato, and
M Katsuyama, and
Y Maeda, and
S Nishikawa, and
M Nakamura
September 1989,
Arzneimittel-Forschung,
